A study of campaign contributions by Big Pharma offers a telling look into why and how drugmakers spend their political-persuasion dollars.
The research report was released by the Washington, D.C.-based consumer rights nonprofit Public Citizen to demonstrate that Big Pharma is throwing big bucks at elected officials who are opposed to the Obama administration’s attempt to overturn or revise key pieces of Medicare subsections that address reimbursements for pharmaceuticals.
Medicare Part B has become a late-term target of the administration, largely, political analysts say, because it was created by Republicans as a way of rewarding their Big Pharma supporters.
Continue Reading for Free
Register and gain access to:
- Breaking benefits news and analysis, on-site and via our newsletters and custom alerts
- Educational webcasts, white papers, and ebooks from industry thought leaders
- Critical converage of the property casualty insurance and financial advisory markets on our other ALM sites, PropertyCasualty360 and ThinkAdvisor
Already have an account? Sign In Now
© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.
Dan Cook
Dan Cook is a journalist and communications consultant based in Portland, OR. During his journalism career he has been a reporter and editor for a variety of media companies, including American Lawyer Media, BusinessWeek, Newhouse Newspapers, Knight-Ridder, Time Inc., and Reuters. He specializes in health care and insurance related coverage for BenefitsPRO.
